Pulmonary tumor thrombotic microangiopathy due to lung adenocarcinoma with ROS1 rearrangement successfully treated with Crizotinib under veno-arterial extracorporeal membrane oxygenation.
2 September 2019 (14:30 - 14:47)
Organised by:
Slides
About the speaker

Fukui University Hospital, Fukui (Japan)
3 More presentations in this session
Access the full session
The Event
ESC Congress 2019
2 September 2019
14:30 CET



